553 related articles for article (PubMed ID: 30911997)
1. The effectiveness of metformin, oral contraceptives, and lifestyle modification in improving the metabolism of overweight women with polycystic ovary syndrome: a network meta-analysis.
Wang A; Mo T; Li Q; Shen C; Liu M
Endocrine; 2019 May; 64(2):220-232. PubMed ID: 30911997
[TBL] [Abstract][Full Text] [Related]
2. Comparative efficacy of statins, metformin, spironolactone and combined oral contraceptives in reducing testosterone levels in women with polycystic ovary syndrome: a network meta-analysis of randomized clinical trials.
Almalki HH; Alshibani TM; Alhifany AA; Almohammed OA
BMC Womens Health; 2020 Apr; 20(1):68. PubMed ID: 32248801
[TBL] [Abstract][Full Text] [Related]
3. A comparative systematic review of Yasmin (drospirenone pill) versus standard treatment options for symptoms of polycystic ovary syndrome.
Li J; Ren J; Sun W
Eur J Obstet Gynecol Reprod Biol; 2017 Mar; 210():13-21. PubMed ID: 27923166
[TBL] [Abstract][Full Text] [Related]
4. Insulin Sensitizers for Improving the Endocrine and Metabolic Profile in Overweight Women With PCOS.
Xing C; Li C; He B
J Clin Endocrinol Metab; 2020 Sep; 105(9):2950-63. PubMed ID: 32490533
[TBL] [Abstract][Full Text] [Related]
5. Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis.
Naderpoor N; Shorakae S; de Courten B; Misso ML; Moran LJ; Teede HJ
Hum Reprod Update; 2015; 21(5):560-74. PubMed ID: 26060208
[TBL] [Abstract][Full Text] [Related]
6. Effects of drospirenone-ethinylestradiol and/or metformin on CD4(+)CD28(null) T lymphocytes frequency in women with hyperinsulinemia having polycystic ovary syndrome: a randomized clinical trial.
Moro F; Morciano A; Tropea A; Sagnella F; Palla C; Scarinci E; Ciardulli A; Martinez D; Familiari A; Liuzzo G; Tritarelli A; Cosentino N; Niccoli G; Crea F; Lanzone A; Apa R
Reprod Sci; 2013 Dec; 20(12):1508-17. PubMed ID: 23690338
[TBL] [Abstract][Full Text] [Related]
7. Comparative efficacy of oral insulin sensitizers metformin, thiazolidinediones, inositol, and berberine in improving endocrine and metabolic profiles in women with PCOS: a network meta-analysis.
Zhao H; Xing C; Zhang J; He B
Reprod Health; 2021 Aug; 18(1):171. PubMed ID: 34407851
[TBL] [Abstract][Full Text] [Related]
8. Effects and plasma proteomic analysis of GLP-1RA versus CPA/EE, in combination with metformin, on overweight PCOS women: a randomized controlled trial.
Liao M; Li X; Zhang H; Zhou L; Shi L; Li W; Shen R; Peng G; Zhao H; Shao J; Wang X; Sun Z; Zheng H; Long M
Endocrine; 2024 Jan; 83(1):227-241. PubMed ID: 37653215
[TBL] [Abstract][Full Text] [Related]
9. The comparative effectiveness of 55 interventions in obese patients with polycystic ovary syndrome: A network meta-analysis of 101 randomized trials.
Abdel-Maboud M; Menshawy A; Hasabo EA; Abdelraoof MI; Alshandidy M; Eid M; Menshawy E; Outani O; Menshawy A
PLoS One; 2021; 16(7):e0254412. PubMed ID: 34280195
[TBL] [Abstract][Full Text] [Related]
10. Endothelial function and insulin resistance in polycystic ovary syndrome: the effects of medical therapy.
Teede HJ; Meyer C; Hutchison SK; Zoungas S; McGrath BP; Moran LJ
Fertil Steril; 2010 Jan; 93(1):184-91. PubMed ID: 19019358
[TBL] [Abstract][Full Text] [Related]
11. Effect of orlistat during individualized comprehensive life-style intervention on visceral fat in overweight or obese PCOS patients.
Min M; Ruan X; Wang H; Cheng J; Luo S; Xu Z; Li M; Mueck AO
Gynecol Endocrinol; 2022 Aug; 38(8):676-680. PubMed ID: 35723579
[No Abstract] [Full Text] [Related]
12. Effect of lifestyle modification and metformin therapy on emerging cardiovascular risk factors in overweight Indian women with polycystic ovary syndrome.
Rajagopal G; Reddy AP; Venkata Harinarayan C; Suresh V; Bitla A; P V L N Rao S; Sachan A
Metab Syndr Relat Disord; 2012 Aug; 10(4):273-9. PubMed ID: 22468948
[TBL] [Abstract][Full Text] [Related]
13. Effects of oral contraceptives on metabolic profile in women with polycystic ovary syndrome: A meta-analysis comparing products containing cyproterone acetate with third generation progestins.
Amiri M; Ramezani Tehrani F; Nahidi F; Kabir A; Azizi F; Carmina E
Metabolism; 2017 Aug; 73():22-35. PubMed ID: 28732568
[TBL] [Abstract][Full Text] [Related]
14. Ethinyl estradiol-drospirenone vs ethinyl estradiol-drospirenone plus metformin in the treatment of lean women with polycystic ovary syndrome.
Cinar N; Harmanci A; Bayraktar M; Yildiz BO
Clin Endocrinol (Oxf); 2013 Mar; 78(3):379-84. PubMed ID: 22509734
[TBL] [Abstract][Full Text] [Related]
15. Effect of chlormadinone acetate versus drospirenone-containing oral contraceptives on the endocrinal features of women with polycystic ovary syndrome: Systematic review and meta-analysis of randomized clinical trials.
Menshawy A; Ismail A; Abdel-Maboud M; El-Din AA; Elgebaly A; Gadelkarim M; Bahbah EI; Abdelghany MF; Samy A; Abbas AM
J Gynecol Obstet Hum Reprod; 2019 Nov; 48(9):763-770. PubMed ID: 30940512
[TBL] [Abstract][Full Text] [Related]
16. The impact of metformin with or without lifestyle modification versus placebo on polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials.
Melin J; Forslund M; Alesi S; Piltonen T; Romualdi D; Spritzer PM; Tay CT; Pena A; Witchel SF; Mousa A; Teede H
Eur J Endocrinol; 2023 Aug; 189(2):S37-S63. PubMed ID: 37536294
[TBL] [Abstract][Full Text] [Related]
17. Effect of orlistat or metformin in overweight and obese polycystic ovary syndrome patients with insulin resistance.
Song J; Ruan X; Gu M; Wang L; Wang H; Mueck AO
Gynecol Endocrinol; 2018 May; 34(5):413-417. PubMed ID: 29172796
[TBL] [Abstract][Full Text] [Related]
18. Effects of long-term administration of an oral contraceptive containing ethinylestradiol and cyproterone acetate on lipid metabolism in women with polycystic ovary syndrome.
Falsetti L; Pasinetti E
Acta Obstet Gynecol Scand; 1995 Jan; 74(1):56-60. PubMed ID: 7856434
[TBL] [Abstract][Full Text] [Related]
19. Effect of the combined oral contraceptive pill and/or metformin in the management of polycystic ovary syndrome: A systematic review with meta-analyses.
Teede H; Tassone EC; Piltonen T; Malhotra J; Mol BW; Peña A; Witchel SF; Joham A; McAllister V; Romualdi D; Thondan M; Costello M; Misso ML
Clin Endocrinol (Oxf); 2019 Oct; 91(4):479-489. PubMed ID: 31087796
[TBL] [Abstract][Full Text] [Related]
20. Comparison of effects of 3 mg drospirenone plus 20 μg ethinyl estradiol alone or combined with metformin or cyproterone acetate on classic metabolic cardiovascular risk factors in nonobese women with polycystic ovary syndrome.
Fruzzetti F; Perini D; Lazzarini V; Parrini D; Gambacciani M; Genazzani AR
Fertil Steril; 2010 Oct; 94(5):1793-8. PubMed ID: 19931080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
